Clinical Characteristics of Patients with co-Existent Diabetic Peripheral Neuropathy and Depression: A Systematic Review

Abstract

Objectives Both diabetic peripheral neuropathy and depression have significant implications on patients’ quality of life, management and outcomes. We aimed to evaluate all available evidence concerning patients with co-existent diabetic peripheral neuropathy and depression, and describe their clinical characteristics, in order to promote early recognition and management.

Methods Systematic search of PubMed for studies providing data on patients with diabetic peripheral neuropathy and depression. The primary outcome was to evaluate all available evidence related to characteristics of diabetes, diabetic peripheral neuropathy and depression. Secondary study outcomes included comorbid conditions and complications in these patients.

Results Final analysis included 24 studies with data on 205 patients. Most patients were adults between 18–65 years of age. Mean HbA1c value was above 8% and most patients were treated with insulin. Neuropathy was predominantly painful and most patients with available data were considered to have major depressive disorder. In addition to diabetic peripheral neuropathy and depression, diabetes-related complications were recorded in 43 patients, the most common being autonomic neuropathy, retinopathy and nephropathy. The most frequently reported comorbidities were weight loss (72 patients), impotence (60 patients), hypertension (23 patients) and coronary artery disease (22 patients).

Conclusions The present study describes the characteristics of patients with co-existent diabetic peripheral neuropathy and depression, aiming for prompt detection, prevention of further deterioration and improvement of patient outcomes. Available evidence shows that the majority of these patients are adults, with painful peripheral neuropathy and with insulin-treated and inadequately controlled diabetes.

Key words

diabetes mellitus - diabetic peripheral neuropathy - depression - complications

Publikationsverlauf

Eingereicht: 28. Juli 2018
Eingereicht: 24. August 2018

Angenommen: 13. September 2018

Artikel online veröffentlicht:
26. September 2018

• References

• 1 International Diabetes Federation . IDF diabetes atlas. Brussels: International Diabetes Federation; 2015
• 2 Boulton A, Vinik A, Arezzo J. et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962
• 3 Dyck PJ, Kratz KM, Karnes JL. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort The Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824
• 4 Young MJ, Boulton AJM, MacLeod AF. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom Hospital Clinic Population. Diabetologia 1993; 36: 150-154
• 5 Boulton A, Malik R, Arezzo J. et al. Diabetic Somatic Neuropathies. Diabetes Care 2004; 27: 1458-1486
• 6 Tesfaye S, Boulton AJM, Dyck PJ. et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293
• 7 Gore M, Brandenburg NA, Dukes E. et al. Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep. J Pain Symptom Manage 2005; 30: 374-385
• 8 Trikkalinou A, Papazafiropoulou A, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes 2017; 8: 120-129
• 9 Ziegler D, Keller J, Maier C. et al. Diabetic Neuropathy. Exp Clin Endocrinol Diabetes 2014; 122: 406-415
• 10 Ducat L, Philipson LH, Anderson BJ. The Mental Health Comorbidities of Diabetes. JAMA 2014; 312: 691-692
• 11 Gavard JA, Lustman PJ, Clouse RE. Prevalence of Depression in Adults With Diabetes: An epidemiological evaluation. Diabetes Care 1993; 16: 1167-1178
• 12 Golden SH. Examining a Bidirectional Association Between Depressive Symptoms and Diabetes. JAMA 2008; 299: 2751-2759
• 13 Mezuk B, Eaton WW, Albrecht S. et al. Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis. Diabetes Care 2008; 31: 2383-2390
• 14 Vileikyte L, Peyrot M, Gonzalez JS. et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: A longitudinal study. Diabetologia 2009; 52: 1265-1273
• 15 Vileikyte L, Gonzalez JS. Recognition and management of psychosocial issues in diabetic neuropathy. Handb Clin Neurol 2014; 126: 195-209
• 16 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151: 264-269
• 17 Wallace BC, Small K, Brodley CE. et al. Deploying an interactive machine learning system in an evidence-based practice center: Abstrackr. Proc ACM Int Health Inform Symp IHI 2012; 819-824
• 18 Guyatt GH, Oxman AD, Vist GE. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
• 19 Al-Hajeri T, El-Gebely S, Abdella N. Profound weight loss in a type 2 diabetic patient with diabetic neuropathic cachexia: A case report. Diabetes Metab 2009; 35: 422-424
• 20 Archer AG, Watkins PJ, Thomas PK. et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983; 46: 491-499
• 21 Avilés-Santa L, Wolff TK, Raskin P. Intractable vomiting in diabetic patients. J Diabetes Complications 2003; 17: 145-152
• 22 Banaschak S, Bajanowski T, Brinkmann B. Suicide of a diabetic by inducing hyperglycemic coma. Int J Legal Med 2000; 113: 162-163
• 23 Berger A, Dukes E, Edelsberg J. et al. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain 2007; 23: 251-258
• 24 Blau RH. Diabetic neuropathic cachexia: report of a woman with this syndrome and review of the literature. Arch Intern Med 1983; 143: 2011-2012
• 25 Castellano F, Mascias J, Zabala J. et al. Acute painful diabetic neuropathy following severe weight loss. Muscle Nerve 1996; 19: 463-467
• 26 Dardis C, Omoregie E, Ly V. Fatal Serotonin Syndrome Precipitated by Oxcarbazepine in a Patient Using an Selective Serotonin Reuptake Inhibitor. The Neurologist. 2012; 18: 204-205
• 27 D’Costa DF, Price DE, Burden AC. Diabetic neuropathic cachexia associated with malabsorption. Diabet Med 1992; 9: 203-205
• 28 DeOrchis VS, Herskovitz S, Laureta E. et al. Neuropathic Cachexia Associated With Type 1 Diabetes in an Adolescent Girl. Pediatr Neurol 2013; 49: 282-285
• 29 Ernst CR Winter Depression and Diabetes. Crit Care Nurs Clin North Am 2012; 24: 509-518
• 30 Gade GN, Hofeldt FD, Treece GL. Diabetic neuropathic cachexia: beneficial response to combination therapy with amitriptyline and fluphenazine. JAMA 1980; 243: 1160-1161
• 31 Godil A, Berriman D, Knapik S. et al. Diabetic neuropathic cachexia. West J Med 1996; 165: 382
• 32 Kaufman KR, Parikh A, Chan L. et al. Myoclonus in renal failure: Two cases of gabapentin toxicity. Epilepsy Behav Case Rep 2014; 2: 8-10
• 33 Koca TT. Concomitance of diabetic neuropathic amyotrophy and cachexia: A case report with review of the literature. North Clin Istanb 2015; 2: 165-170
• 34 Koch MF, Molnar GD. Psychiatric aspects of patients with unstable diabetes mellitus. Psychosom Med 1974; 36: 57-68
• 35 Max MB, Culnane M, Schafer SC. et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37: 589-596
• 36 Naccache DD, Nseir WB, Herskovitz MZ. et al. Diabetic neuropathic cachexia: A case report. J Med Case Reports 2014; 8: 20
• 37 Orr DP, Golden MP, Myers G. et al. Characteristics of adolescents with poorly controlled diabetes referred to a tertiary care center. Diabetes Care 1983; 6: 170-175
• 38 Pierce D, Holt S, Reeves-Daniel A. A Probable Case of Gabapentin-Related Reversible Hearing Loss in a Patient with Acute Renal Failure. Clin Ther 2008; 30: 1681-1684
• 39 Schilling M, Brueckner-Totonji C, Arolt V. et al. A Case of Multiple Sclerosis Masked by Depression and Diabetic Neuropathy. Psychosomatics 2006; 47: 361-363
• 40 Singh H, Raju M, Dubey V. et al. A study of sociodemographic clinical and glycemic control factors associated with co-morbid depression in type 2 diabetes mellitus. Ind Psychiatry J 2014; 23: 134-142
• 41 Theesen KA, Marsh WR. Relief of diabetic neuropathy with fluoxetine. DICP 1989; 23: 572-574
• 42 Turkington RW. Depression masquerading as diabetic neuropathy. J Am Med Assoc 1980; 243: 1147-1150
• 43 Ritholz MD, Beverly EA, Abrahamson MJ. et al. Physicians’ Perceptions of the Type 2 Diabetes Multi-disciplinary Treatment Team: A Qualitative Study. Diabetes Educ 2011; 37: 794-800
• 44 Gucciardi E, Espin S, Morganti A. et al. Exploring interprofessional collaboration during the integration of diabetes teams into primary care. BMC Fam Pract 2016; 17: 12
• 45 Kishimoto M, Noda M. The difficulties of interprofessional teamwork in diabetes care: A questionnaire survey. J Multidiscip Healthc 2014; 7: 333-339
• 46 Anderson S, Narayanan R, Malipatil N. et al. Socioeconomic deprivation independently predicts painful diabetic neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 2015; 123: 423-427
• 47 Şen H, Şen H, Aşık M. et al. The importance of education in diabetic foot care of patients with diabetic neuropathy. Exp Clin Endocrinol Diabetes 2014; 123: 178-181
• 48 Lin EH, Katon W, Von Korff M. et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154-2160
• 49 D’Amato C, Morganti R, Greco C. et al. Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities. Diab Vasc Dis Res 2016; 13: 418-428
• 50 Yoshida S, Hirai M, Suzuki S. et al. Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry Clin Neurosci 2009; 63: 65-72
• 51 Vileikyte L, Leventhal H, Gonzalez JS. et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005; 28: 2378-2383
• 52 Anderson RJ, Freedland KE, Clouse RE. et al. The prevalence of comorbid depression in adults with diabetes. Diabetes Care 2001; 24: 1069-1078
• 53 van Dooren FEP, Nefs G, Schram MT. et al. Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS ONE 2013; 8: e57058
• 54 Lustman PJ, Anderson RJ, Freedland KE. et al. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942
• 55 Thorve VS, Kshirsagar AD, Vyawahare NS. et al. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 2011; 25: 129-136
• 56 Greene DA, Sima AA, Stevens MJ. et al. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-1925
• 57 Lee JA, Halpern EM, Lovblom LE. et al. Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy. PLoS ONE 2014; 9: e86515
• 58 Perkins BA, Grewal J, Ng E. et al. Validation of a Novel Point-of-Care Nerve Conduction Device for the Detection of Diabetic Sensorimotor Polyneuropathy. Diabetes Care 2006; 29: 2023-2027
• 59 Jin J, Wang W, Gu T. et al. The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population Screening DPN by SUDOSCAN. Exp Clin Endocrinol Diabetes 2018; 126: 472-477
• 60 Jones LE, Doebbeling CC. Depression screening disparities among veterans with diabetes compared with the general veteran population. Diabetes Care 2007; 30: 2216-2221